Adults with moderately to severely active UC (ulcerative colitis) who have been prescribed:
- HUMIRA®, without or in combination with an IMM (6-mercaptopurine or azathioprine), or
- 6-mercaptopurine (6-MP), or
- Azathioprine (AZA)
are needed to participate in a registry study to collect long term safety and effectiveness information. No additional procedures or treatments will be required. Questionnaire may need to be completed and will take part during your routine doctor's visit. For more information, contact Guillermina Cruz at (713) 798-8220 or Guillermina.Cruz@bcm.edu. This research is sponsored by Baylor College of Medicine.